Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready
Phronesis Artificial Intelligence Inc. has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 2 distinct examiners, though they all remain within 1 distinct art unit. This structure indicates that while the technical focus is consistent, the company must manage different examiner perspectives within that single unit. The concentration in 1 distinct art unit suggests a deep but narrow technical specialization for the company's current patenting efforts.
KEENAN NEIL ANDERSON-FEARS is the busiest examiner, overseeing 2 busiest examiner pending office actions. This represents a majority of the 3 pending office actions for the portfolio. The remaining pending action is handled by the other distinct examiner. Managing these 3 pending office actions within the assigned art unit allows for a cohesive technical argument across the portfolio. Practitioners can leverage the consistency of the art unit to develop a unified response strategy, even when dealing with 2 distinct examiners. This distribution requires balancing the specific feedback of the busiest examiner against the broader requirements of the biotechnology sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (67%) |
| §103 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ANDERSON-FEARS, KEENAN NEIL | 2 | 12.0% | +41.3% |
| WOITACH, JOSEPH T | 1 | 49.9% | +28.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17584073 | SYSTEMS AND METHODS FOR TARGETED INTENTIONAL MOLECULAR DESIGN | ANDERSON-FEARS, KEENAN NEIL | 71d |
| 17584053 | SYSTEMS AND METHOD FOR TARGETED MOLECULAR DESIGN | ANDERSON-FEARS, KEENAN NEIL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17584073 | SYSTEMS AND METHODS FOR TARGETED INTENTIONAL MOLECULAR DESIGN | ANDERSON-FEARS, KEENAN NEIL | 71d |
| 17584087 | SYSTEMS AND METHODS FOR APPLYING A TRANSFORMER NETWORK TO SPATIAL DATA | WOITACH, JOSEPH T | — |
| 17584053 | SYSTEMS AND METHOD FOR TARGETED MOLECULAR DESIGN | ANDERSON-FEARS, KEENAN NEIL | — |
| Art Unit | Apps |
|---|---|
| 1687 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17584087 | SYSTEMS AND METHODS FOR APPLYING A TRANSFORMER NETWORK TO SPATIAL DATA | WOITACH, JOSEPH T | 1687 | §103 | Final Rejection | — | Pending | Jan 25, 2022 |
| 17584073 | SYSTEMS AND METHODS FOR TARGETED INTENTIONAL MOLECULAR DESIGN | ANDERSON-FEARS, KEENAN NEIL | 1687 | §101§103§112 | Final Rejection | 71d | Pending | Jan 25, 2022 |
| 17584053 | SYSTEMS AND METHOD FOR TARGETED MOLECULAR DESIGN | ANDERSON-FEARS, KEENAN NEIL | 1687 | §101§103§112DP | Final Rejection | — | Pending | Jan 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial